Skip to main content
. 2023 Dec 7;12(24):7542. doi: 10.3390/jcm12247542

Table 1.

Sociodemographic and vaccination data for survey respondents.

Variable Total, n [7203]
(%) [100]
SLE, n [882]
(%) [12.2]
rAIDs, n [3161]
(%) [43.9]
nrAIDs, n [426]
(%) [5.9]
HCs, n [2734]
(%) [38.0]
Age (median, IQR), years 44 (34–56) 39 (31–50) 52 (41–62) 43 (34–53) 38 (30–49)
Gender F:M 5310:1799
3:1
826:46
18:1
2522:602
4.2:1
351:70
5:1
1611:1081
1.5:1
Ethnicity n (%)
African American or of African origin (Black) 336 (4.7) 89 (10.1) 146 (4.6) 4 (0.9) 97 (3.5)
Asian 1632 (22.7) 263 (29.8) 602 (19.0) 57 (13.4) 710 (26.0)
Caucasian (White) 3039 (42.2) 274 (31.1) 1784 (56.4) 227 (53.3) 754 (27.6)
Do not wish to disclose 262 (3.6) 43 (4.9) 90 (2.8) 14 (3.3) 115 (4.2)
Hispanic 1200 (16.7) 114 (12.9) 283 (9.0) 83 (19.5) 720 (26.3)
Native American, Indigenous, Pacific Islander 53 (0.7) 12 (1.4) 17 (0.5) 4 (0.9) 20 (0.7)
Other 628 (8.7) 80 (9.1) 224 (7.1) 34 (8.0) 290 (10.6)

HCs: health controls; IQR: interquartile range; nrAID: non-rheumatic autoimmune disease; rAID: rheumatic autoimmune disease other than SLE; SLE: systemic lupus erythematosus.